Growth Metrics

Q32 Bio (QTTB) Revenue (2018 - 2023)

Q32 Bio's quarterly Revenue came in at -$1.4 million in Q4 2023, down 269.58% year-on-year from $802000.0 in Q4 2022, and down 173.16% quarter-over-quarter from $1.9 million in Q3 2023.

Q32 Bio has reported Revenue for 6 years, with the latest figure at -$1.4 million in Q4 2023.

  • For the quarter ending Q4 2023, Revenue fell 269.58% year-over-year to -$1.4 million; the trailing twelve-month figure through Sep 2024 stood at -$1.4 million (down 115.43% YoY), and the FY2025 full-year result was $53.7 million, changed N/A from the prior year.
  • Revenue for Q4 2023 stood at -$1.4 million, down from $1.9 million in the prior quarter.
  • The five-year high for Revenue was $29.3 million in Q1 2021, with the low at -$1.4 million in Q4 2023.
  • Average Revenue over 5 years is $2.4 million, with a median of $802000.0 recorded in 2021.
  • Year-over-year, Revenue soared 4883.84% in 2021 and slumped 269.58% in 2023.
  • Tracing QTTB's Revenue over 5 years: stood at $563000.0 in 2019, then jumped by 74.07% to $980000.0 in 2020, then declined by 18.16% to $802000.0 in 2021, then changed by 0.0% to $802000.0 in 2022, then tumbled by 269.58% to -$1.4 million in 2023.
  • The last three Revenue figures came in at -$1.4 million (Q4 2023), $1.9 million (Q3 2023), and $3.2 million (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 306.30 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 2.99 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 3.61 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.17 Bn
10 Q32 Bio 162.94 Mn 112.19 Mn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2023 -1.36 Mn
Sep 30, 2023 1.86 Mn
Jun 30, 2023 3.21 Mn
Mar 31, 2023 2.95 Mn
Dec 31, 2022 802,000.00
Sep 30, 2022 802,000.00
Jun 30, 2022 802,000.00
Mar 31, 2022 802,000.00
Dec 31, 2021 802,000.00
Sep 30, 2021 1.68 Mn
Jun 30, 2021 2.19 Mn
Mar 31, 2021 29.31 Mn
Dec 31, 2020 980,000.00
Sep 30, 2020 567,000.00
Jun 30, 2020 567,000.00
Mar 31, 2020 588,000.00
Dec 31, 2019 563,000.00
Sep 30, 2019 441,000.00
Jun 30, 2019 392,000.00
Mar 31, 2019 270,000.00
Dec 31, 2018 1.20 Mn
Sep 30, 2018 1.60 Mn
Jun 30, 2018 1.40 Mn
Mar 31, 2018 1.13 Mn